S.M.A.I.O S.A. (EPA:ALSMA)

Market Cap	42.58M +101.4%
Revenue (ttm)	9.16M +66.7%
Net Income	-2.23M
EPS	-0.41
Shares Out	5.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	460
Open	7.58
Previous Close	7.88
Day's Range	7.58 - 7.60
52-Week Range	5.20 - 9.10
Beta	0.53
Analysts	Strong Buy
Price Target	8.55 (+12.8%)
Earnings Date	Oct 13, 2026

About S.M.A.I.O

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHECK, take control of the outcome data; and i-LEARN, take control of the education. S.M.A.I.O S.A. was incorporated in 2009 and is based in Saint-Priest,...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2009
• Employees: 45
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSMA

Financial Performance

In 2025, S.M.A.I.O's revenue was 9.16 million, an increase of 66.67% compared to the previous year's 5.50 million. Losses were -2.23 million, -5.11% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ALSMA stock is "Strong Buy." The 12-month stock price target is €8.55, which is an increase of 12.80% from the latest price.

Price Target

€8.55

(12.80% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 23, 2026

Data Sources Report a data error